STOP: The staff smoking project

INTERVENTION: The researchers will initially recruit 50 people to the study. Participants will be randomised to either standard care, or to receive our help to quit program. The researchers will advertise the study through our internal communications via email, on the intranet and on the hospital social media. The study will only be available to any Portsmouth Hospital Trust staff member working at the Queen Alexandra site. All participants will have a chance to consider participation in the trial and will be asked to consent to their involvement. Information sheets will be given to the participants with time to ask questions and to decide whether they want to participate in the study. Participants are under no obligation to take part in the study and it will not affect their usual care. Those who are randomised to standard care will be offered the opportunity to receive the intervention at 6 months, if it has been shown to be successful. Both groups will be consented by the research team and independently randomised to either the intervention group or the standard care group. All participants will be asked to complete a set of standard questionnaires before the start of the trial, midway through the trial( 4 weeks) and at 12 and 24 weeks. The Intervention Following informed consent, the participant will have a 1:1 meeting with a smoking cessation counsellor to discuss their individual requirements for smoking cessation and be offered their choice of pharmacological intervention. They will be provided with their choice of pharmacotherapy immediately. They will then be invited to attend a group session, where they will have some brief lung function tests and check carbon monoxide levels. Participants will be offered refreshments and receive a bespoke group session to address various a CONDITION: Smoking cessation to prevent respiratory disease in hospital staff ; Respiratory INCLUSION CRITERIA: 1. Male or Female, aged 18 years or over 2. Willing and able to give informed consent for participation in the study. 3. Must work for PHT at QAH and be able to attend weekly meetings for the duration of the study period 4. Must be a current smoker PRIMARY OUTCOME: ; 1. Study process indicators measured by:; 1.1. The recruitment and retention rate; 1.2. Process indicators measured by completion rates of outcome questionnaires and assessments; 2. Qualitative outcomes measured by participants’ perceptions of the study, the intervention, including ease of attendance to group meetings and acceptability of the intervention; 3. Clinical and behavioural outcomes measured by:; 3.1. Number of smokers who achieved a successful quit measured at 4 weeks, 12 weeks and 6 months – smoking status Fagerstrom Test for Nicotine Dependence (FTND); 3.2. Spirometry at weekly intervals; 3.3. Intention to stop smoking at baseline, 4, 12 and 24 weeks – intention to quit smoking questionnaire; 3.4. Smoking behaviours at baseline, 4, 12 and 24 weeks – smoking specific compensatory health beliefs questionnaire; 3.5. Smoking self efficacy at baseline, 4, 12 and 24 weeks – self efficacy to quit smoking questionnaire; 3.6. Smoking self quality of life at baseline, 4, 12 and 24 weeks – quality of life questionnaire; 3.7. Change in exercise behaviour at baseline, 4, 12 and 24 weeks – international physical activity questionnaire (short form); 3.8. Change in alcohol behaviour at baseline, 4, 12 and 24 weeks measured in units per week; 3.9. Change in weight and BMI at baseline, 4, 12 and 24 weeks; 4. Cost effectiveness outcomes measured by:; 4.1. Number of sick days in the 6 months prior to intervention; 4.2. Number of sick days during the intervention; 4.3. Time spent away from the work place in the 6 months prior to the intervention (hours); 4.4. Time spent away from the work place during the intervention (hours); 4.5. Number of attendances at other NHS services seeking medical help for smoking related conditions;